Latest Insights - page 65 | BiopharmaTrend

Cytomos Launches Benchtop Cell Analyzer

Cytomos has introduced Celledonia, a benchtop cell analyzer that promises to transform bioprocessing by delivering near real-time, cell-specific insights. Utilizing Cytomos’ patented AuraCyt platform, Celledonia aims to expedite development and …

Continue ›››

Lantern Pharma Receives Japanese Patent for Oncology Drug Candidate LP-284

Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted a patent for their drug candidate LP-284, a novel small …

Continue ›››

Lokavant Introduces AI Solution for Comprehensive Clinical Trial Optimization

Lokavant has unveiled Spectrum, an AI software solution designed to enhance clinical trial feasibility and optimization throughout the entire clinical development process. This platform enables study teams to predict, manage, …

Continue ›››

New LENSai API by BioStrand Integrates Large Language Models with Health Data for Advanced Drug Development

BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (IPA), has launched its new LENSai API software, designed to integrate large databases and electronic health records with advanced large language models. This …

Continue ›››

The Rise of Cyclic Peptides: Bridging the Gap in Modern Medicine

Cyclic peptides, characterized by their unique ring structures, represent an emerging trend in drug discovery due to their ability to bridge the gap between small molecules and biologics.

Continue ›››

Envisagenics Secures $25 Million Series B Funding to Advance RNA Splicing Therapeutics

Envisagenics, an AI-enabled biotechnology firm specializing in RNA splicing therapeutics, has announced the completion of its Series B funding round. This round included investments from existing supporters Third Kind Venture …

Continue ›››

FDA and CluePoints Extend Collaboration to Enhance Clinical Trial Data Integrity with AI and Machine Learning

The Food and Drug Administration (FDA) and CluePoints, a provider of statistical and AI-driven software solutions, have entered a new three-year Cooperative Research and Development Agreement (CRADA). This agreement aims …

Continue ›››

Nobel Laureate Inaugurates New Molecular Devices Facility for Manufacturing Patient-Derived Organoids

Molecular Devices, LLC, a leader in high-performance life science solutions, has officially opened its state-of-the-art facility in Cardiff, UK. This multi-million-pound site is designed for the company’s proprietary bioprocess workflow …

Continue ›››

Merck KGaA Partners with Biolojic Design for $376M Antibody-Drug Conjugate Development

Merck KGaA has entered into a collaboration with Biolojic Design to develop new oncology and immunology therapeutics using Biolojic’s AI-driven drug discovery platform.

Continue ›››

Paige Introduces Multi-Modal AI for Enhanced Precision Oncology and Drug Discovery

Paige, a provider of digital pathology solutions and AI applications, has launched a new service line leveraging its Foundation Models. These models include a large multi-modal AI model in pathology …

Continue ›››

Insmed Announces Positive Results from ASPEN Study of Brensocatib in Bronchiectasis Patients

Insmed Incorporated has reported positive topline results from the ASPEN study, a pivotal Phase III clinical trial evaluating the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis …

Continue ›››

ExpressionEdits Raises $13M for AI-Based Protein Expression Technology

ExpressionEdits, a biotechnology company focused on optimizing protein expression through AI and proprietary intronization technology, has raised $13 million in seed funding. The round was co-led by Octopus Ventures and …

Continue ›››